TY - JOUR
T1 - Peroxisome proliferator-activated receptor α gene regulates left ventricular growth in response to exercise and hypertension
AU - Jamshidi, Yalda
AU - Montgomery, Hugh E.
AU - Hense, Hans Werner
AU - Myerson, Saul G.
AU - Pineda Torra, Ines
AU - Staels, Bart
AU - World, Michael J.
AU - Doering, Angela
AU - Erdmann, Jeanette
AU - Hengstenberg, Christian
AU - Humphries, Steve E.
AU - Schunkert, Heribert
AU - Flavell, David M.
PY - 2002/2/26
Y1 - 2002/2/26
N2 - Background-Left ventricular hypertrophy (LVH) occurs as an adaptive response to a physiological (such as exercise) or pathological (valvular disease, hypertension, or obesity) increase in cardiac work. The molecular mechanisms regulating the LVH response are poorly understood. However, inherited defects in fatty acid oxidation are known to cause severe early-onset cardiac hypertrophy. Peroxisome proliferator-activated receptor α (PPARα) regulates genes responsible for myocardial fatty acid oxidation and is downregulated during cardiac hypertrophy, concomitant with the switch from fatty acid to glucose utilization. Methods and Results-The role of PPARα in left ventricular growth was investigated in 144 young male British Army recruits undergoing a 10-week physical training program and in 1148 men and women participating in the echocardiographic substudy of the Third Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) Augsburg study. A G/C polymorphism in intron 7 of the PPARα gene significantly influenced left ventricular (LV) growth in response to exercise (P=0.009). LV mass increased by 6.7±1.5 g in G allele homozygotes but was significantly greater in heterozygotes for the C allele (11.8±1.9 g) and in CC homozygotes (19.4±4.2 g). Likewise, C allele homozygotes had significantly higher LV mass, which was greater still in hypertensive subjects, and a higher prevalence of LVH in the Third MONICA Augsburg study. Conclusions-We demonstrate that variation in the PPARα gene influences human left ventricular growth in response to exercise and hypertension, indicating that maladaptive cardiac substrate utilization can play a causative role in the pathogenesis of LVH.
AB - Background-Left ventricular hypertrophy (LVH) occurs as an adaptive response to a physiological (such as exercise) or pathological (valvular disease, hypertension, or obesity) increase in cardiac work. The molecular mechanisms regulating the LVH response are poorly understood. However, inherited defects in fatty acid oxidation are known to cause severe early-onset cardiac hypertrophy. Peroxisome proliferator-activated receptor α (PPARα) regulates genes responsible for myocardial fatty acid oxidation and is downregulated during cardiac hypertrophy, concomitant with the switch from fatty acid to glucose utilization. Methods and Results-The role of PPARα in left ventricular growth was investigated in 144 young male British Army recruits undergoing a 10-week physical training program and in 1148 men and women participating in the echocardiographic substudy of the Third Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) Augsburg study. A G/C polymorphism in intron 7 of the PPARα gene significantly influenced left ventricular (LV) growth in response to exercise (P=0.009). LV mass increased by 6.7±1.5 g in G allele homozygotes but was significantly greater in heterozygotes for the C allele (11.8±1.9 g) and in CC homozygotes (19.4±4.2 g). Likewise, C allele homozygotes had significantly higher LV mass, which was greater still in hypertensive subjects, and a higher prevalence of LVH in the Third MONICA Augsburg study. Conclusions-We demonstrate that variation in the PPARα gene influences human left ventricular growth in response to exercise and hypertension, indicating that maladaptive cardiac substrate utilization can play a causative role in the pathogenesis of LVH.
UR - http://www.scopus.com/inward/record.url?scp=0037176933&partnerID=8YFLogxK
U2 - 10.1161/hc0802.104535
DO - 10.1161/hc0802.104535
M3 - Journal articles
C2 - 11864924
AN - SCOPUS:0037176933
SN - 0009-7322
VL - 105
SP - 950
EP - 955
JO - Circulation
JF - Circulation
IS - 8
ER -